Umezu T - Search Results

1

Effect of COVID-19 infection on the gastrointestinal tract considering preventive methods during endoscopic procedures.

Naito S, Nakamura I, Umezu T, Hata A, Madarame A, Uchida K, Koyama Y, Morise T, Yamaguchi H, Kono S, Sugimoto M, Kawai T, Harada Y, Kuroda M, Fukuzawa M, Itoi T. Naito S, et al. Among authors: umezu t. DEN Open. 2023 Aug 27;4(1):e290. doi: 10.1002/deo2.290. eCollection 2024 Apr. DEN Open. 2023. PMID: 37644959 Free PMC article.

2

Postoperative subphrenic abscess following gastrectomy for gastric cancer.

Takeda J, Hashimoto K, Tanaka T, Koufuji K, Umezu T, Kakegawa T. Takeda J, et al. Among authors: umezu t. Kurume Med J. 1990;37(3):165-70. doi: 10.2739/kurumemedj.37.165. Kurume Med J. 1990. PMID: 2283837 Free article.

3

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.

Kubota S, Tokunaga K, Umezu T, Yokomizo-Nakano T, Sun Y, Oshima M, Tan KT, Yang H, Kanai A, Iwanaga E, Asou N, Maeda T, Nakagata N, Iwama A, Ohyashiki K, Osato M, Sashida G. Kubota S, et al. Among authors: umezu t. Nat Commun. 2019 Aug 28;10(1):3943. doi: 10.1038/s41467-019-11919-x. Nat Commun. 2019. PMID: 31462675 Free PMC article.

4

Early gastric cancer following gastrojejunostomy without gastrectomy.

Umezu T, Takeda J, Tanaka T, Koufuji K, Hashimoto K, Kakegawa T. Umezu T, et al. Kurume Med J. 1991;38(3):187-90. doi: 10.2739/kurumemedj.38.187. Kurume Med J. 1991. PMID: 1779606 Free article.

5

Surgical management of residual gastric cancer.

Takeda J, Hashimoto K, Koufuji K, Umezu T, Tanaka T, Kodama I, Iwai H, Kakegawa T. Takeda J, et al. Among authors: umezu t. Kurume Med J. 1989;36(4):167-72. doi: 10.2739/kurumemedj.36.167. Kurume Med J. 1989. PMID: 2639226 Free article.

6

Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.

Azuma K, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Ohyashiki K, Ohyashiki JH. Azuma K, et al. Among authors: umezu t. Leuk Res. 2017 Nov;62:23-28. doi: 10.1016/j.leukres.2017.09.008. Epub 2017 Sep 21. Leuk Res. 2017. PMID: 28964959

7

Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease.

Soeda S, Ohyashiki JH, Ohtsuki K, Umezu T, Setoguchi Y, Ohyashiki K. Soeda S, et al. Among authors: umezu t. Int J Mol Med. 2013 Mar;31(3):533-9. doi: 10.3892/ijmm.2013.1251. Epub 2013 Jan 21. Int J Mol Med. 2013. PMID: 23338559

8

Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors.

Asano M, Umezu T, Katagiri S, Kobayashi C, Tauchi T, Gotoh M, Ando K, Okabe S, Ohyashiki JH, Ohyashiki K. Asano M, et al. Among authors: umezu t. Int J Hematol. 2017 Apr;105(4):419-422. doi: 10.1007/s12185-017-2199-z. Epub 2017 Feb 14. Int J Hematol. 2017. PMID: 28197964

9

The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients.

Katagiri S, Umezu T, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: umezu t. Br J Haematol. 2013 Jan;160(2):269-71. doi: 10.1111/bjh.12111. Epub 2012 Nov 1. Br J Haematol. 2013. PMID: 23116058 Free article. No abstract available.

10

Esophageal invasion by an upper gastric cancer: retrospective evaluation and prognosis.

Takeda J, Hashimoto K, Koufuji K, Tanaka T, Umezu T, Yasumoto K, Kakegawa T. Takeda J, et al. Among authors: umezu t. Kurume Med J. 1989;36(2):75-9. doi: 10.2739/kurumemedj.36.75. Kurume Med J. 1989. PMID: 2586076 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page